Cohen & Steers, Inc. logo CNS - Cohen & Steers, Inc.

Price: -- -- | CONSENSUS: Sell DETAILS
STRONG
BUY
0
BUY 4
HOLD 4
SELL 5
STRONG
SELL
0
| PRICE TARGET: $88.00 DETAILS
HIGH: $88.00
LOW: $88.00
MEDIAN: $88.00
CONSENSUS: $88.00
UPSIDE: 6.50%

Stock News

CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference

CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference

Video webcast now available here HOUSTON, TX / ACCESS Newswire / August 27, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it participated in the Virtual Investor "Why Now" on-demand conference. Rami Levin, President and Chief Executive Officer of CNS Pharmaceuticals, highlighted the Company's strategic transformation that is being built on the strength of its newly assembled executive leadership team, enhanced financial position following its recent financing, and disciplined approach to evaluating differentiated assets.

Aug 27, 2026 05:01 AM accessnewswire.com
Corero Network Security Launches AI-Augmented Cloud-Assist for SmartWall ONE™

Corero Network Security Launches AI-Augmented Cloud-Assist for SmartWall ONE™

Combining Cloud-Scale AI Analysis With Human Expertise for Enhanced Threat Responses LONDON, Aug. 20, 2026 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service ("DDoS") protection specialists and champion of adaptive, real-time service availability, today announced AI-Augmented Cloud-Assist for SmartWall ONE™, extending its automated DDoS protection with cloud-delivered AI analysis, threat intelligence, and policy optimization. As cybercriminals increasingly leverage AI to develop and evolve attack campaigns, defenders must respond with equal speed and precision.

Aug 20, 2026 03:00 AM prnewswire.com
Cohen & Steers Announces Changes to Realty Indexes

Cohen & Steers Announces Changes to Realty Indexes

NEW YORK, Aug. 14, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio Index (IRP), effective as of the close of business on August 21, 2026. Cohen & Steers Realty Majors Portfolio Index (RMP) Added component (symbol) Removed component (symbol) CareTrust REIT Inc. (CTRE) Cohen & Steers Global Realty Majors Portfolio Index (GRM) Added component (symbol) Removed component (symbol) CareTrust REIT Inc. (CTRE) TAG Immobilien AG (TEG.GR) Vonovia SE (VNA.GR) Keppel DC REIT (KDCREIT.SP) KDX Realty Investment Corp. (8972.JP) Cohen & Steers International Realty Majors Portfolio Index (IRP) Added component (symbol) Removed component (symbol) TAG Immobilien AG (TEG.GR) LEG Immobilien AG (LEG.GR) Keppel DC REIT (KDCREIT.SP) KDX Realty Investment Corp. (8972.JP) These free-float adjusted, modified market capitalization-weighted total return indexes of selected real estate equity securities are quoted intraday on a real-time basis by the Chicago Mercantile Exchange.

Aug 14, 2026 12:05 PM prnewswire.com
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

Company reports approximately $20.0 million cash position and extended operating runway following oversubscribed $22.5 million financing, as it advances its pivot toward a diversified, high-value pipeline HOUSTON, TX / ACCESS Newswire / August 12, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today reported financial results for the second quarter ended June 30, 2026 and provided an update on the corporate strategy the company introduced in March 2026. "We are moving with speed and discipline to transform this company," said Rami Levin, President and Chief Executive Officer of CNS Pharmaceuticals.

Aug 12, 2026 04:00 AM accessnewswire.com
Medincell's Dr Grace Kim to Participate in Piper Sandler CNS Symposium

Medincell's Dr Grace Kim to Participate in Piper Sandler CNS Symposium

MONTPELLIER, France--(BUSINESS WIRE)--Medincell (Euronext Paris: MEDCL), a clinical- and commercial-stage innovation-driven biopharmaceutical company developing and licensing long-acting injectable treatments across multiple therapeutic areas, announced today that Dr Grace Kim, Chief Strategy Officer, U.S. Finance, will take part in the annual Piper Sandler CNS Symposium Thursday, August 13, 2026. Dr Kim will engage with investors in a fireside discussion led by Piper Sandler analysts at 12:30.

Aug 11, 2026 08:30 AM businesswire.com
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for July 2026

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for July 2026

NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $102.5 billion at July 31, 2026, an increase of $2.4 billion from assets under management of $100.1 billion at June 30, 2026. The increase was due to market appreciation of $1.9 billion and net inflows of $688 million, partially offset by distributions of $155 million.

Aug 10, 2026 12:18 PM prnewswire.com
Corero Network Security Strengthens Position as Leader and Innovator in 2026 DDoS SPARK Matrix™

Corero Network Security Strengthens Position as Leader and Innovator in 2026 DDoS SPARK Matrix™

Elevated ranking reflects continued market momentum and customer confidence in Corero's real-time DDoS protection portfolio LONDON, Aug. 6, 2026 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service ("DDoS") protection specialists and champion of adaptive, real-time service availability, today announced it has strengthened its position as a Leader and maintained its standing as the only Emerging Innovator in the 2026 SPARK Matrix™ for DDoS Mitigation, published by global advisory firm QKS Group. Corero's advancement within the top right leader's quadrant reflects sustained market momentum, deeper global partnerships, and growing customer confidence in Corero's SmartWall ONE ™ and CORE solutions.

Aug 06, 2026 03:00 AM prnewswire.com
Cerenome Launches as an Integrated CNS Oncology Company

Cerenome Launches as an Integrated CNS Oncology Company

HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announces that its corporate rebrand to Cerenome will be completed as scheduled. Effective August 3, 2026, the Company's name will become Cerenome, Inc. The Company's common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol “CNSY,” effective market open on the same day.

Jul 31, 2026 04:30 AM globenewswire.com
Cohen & Steers Closed-end Opportunity Fund, Inc. Issues Important Notice Regarding Change in Investment Policy and Investment Strategy

Cohen & Steers Closed-end Opportunity Fund, Inc. Issues Important Notice Regarding Change in Investment Policy and Investment Strategy

NEW YORK, July 29, 2026 /PRNewswire/ -- Cohen & Steers Closed-end Opportunity Fund, Inc. (NYSE:FOF) (the "Fund"), announced today that the Fund's Board of Directors has approved certain changes to the Fund's 80% investment policy and related investment strategy disclosure. The changes will be effective October 1, 2026 (the "Effective Time").

Jul 29, 2026 12:05 PM prnewswire.com
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on July 31, 2026 and cumulative distributions paid fiscal year-to-date. In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

Jul 28, 2026 01:47 PM prnewswire.com
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)

Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, July 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the distribution to be paid on July 31, 2026 and cumulative distributions paid fiscal year-to-date. In December 2011, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

Jul 28, 2026 01:36 PM prnewswire.com

Price Targets